Fox-Fordyce Disease Clinical Presentation

1. Fox G, Fordyce J. Two cases of a rare papular disease affecting the axillary region. J Cutan Genito-Urinary Dis. 1902. 20:1-5.

2. Helou J, Maatouk I, Moutran R, Obeid G. Fox-Fordyce-like disease following laser hair removal appearing on all treated areas. Lasers Med Sci. 2013 Jan 15. [QxMD MEDLINE Link].

3. Alés-Fernández M, Ortega-Martínez de Victoria L, García-Fernández de Villalta MJ. Lesions in the axilla after hair removal using intense pulsed light. Fox-Fordyce disease. Actas Dermosifiliogr. 2015 Jan-Feb. 106 (1):61-2. [QxMD MEDLINE Link].

4. Bernad I, Gil P, Lera JM, Giménez de Azcárate A, Irarrazaval I, Idoate MÁ. Fox Fordyce disease as a secondary effect of laser hair removal. J Cosmet Laser Ther. 2014 Jun. 16 (3):141-3. [QxMD MEDLINE Link].

5. Sammour R, Nasser S, Debahy N, El Habr C. Fox-Fordyce Disease: An under-diagnosed adverse event of laser hair removal?. J Eur Acad Dermatol Venereol. 2016 Sep. 30 (9):1578-82. [QxMD MEDLINE Link].

6. Zargari O, Azimi SZ. Fox Fordyce disease: a side effect of laser therapy. J Cosmet Laser Ther. 2020 Apr 2. 22 (3):126-127. [QxMD MEDLINE Link].

7. Salloum A, Bouferraa Y, Bazzi N, et al. Pathophysiology, clinical findings, and management of Fox-Fordyce disease: A systematic review. J Cosmet Dermatol. 2022 Feb. 21 (2):482-500. [QxMD MEDLINE Link].

8. Singal A, Kaur I, Jakhar D. Fox-Fordyce Disease: Dermoscopic Perspective. Skin Appendage Disord. 2020 Jul. 6 (4):247-249. [QxMD MEDLINE Link]. [Full Text].

9. Stashower ME, Krivda SJ, Turiansky GW. Fox-Fordyce disease: diagnosis with transverse histologic sections. J Am Acad Dermatol. 2000 Jan. 42 (1 Pt 1):89-91. [QxMD MEDLINE Link].

10. Shelley WB, Levy EJ. Apocrine sweat retention in man. II. Fox-Fordyce disease (apocrine miliaria). AMA Arch Derm. 1956 Jan. 73(1):38-49. [QxMD MEDLINE Link].

11. Ranalletta M, Rositto A, Drut R. Fox-Fordyce disease in two prepubertal girls: histopathologic demonstration of eccrine sweat gland involvement. Pediatr Dermatol. 1996 Jul-Aug. 13(4):294-7. [QxMD MEDLINE Link].

12. Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. J Am Acad Dermatol. 2003 Mar. 48(3):453-5. [QxMD MEDLINE Link].

13. Bormate AB Jr, Leboit PE, McCalmont TH. Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases. Arch Dermatol. 2008 Aug. 144(8):1020-4. [QxMD MEDLINE Link].

14. Macarenco RS, Garces S JC. Dilation of apocrine glands. A forgotten but helpful histopathological clue to the diagnosis of axillary Fox-Fordyce disease. Am J Dermatopathol. 2009 Jun. 31(4):393-7. [QxMD MEDLINE Link].

15. Miller ML, Harford RR, Yeager JK. Fox-Fordyce disease treated with topical clindamycin solution. Arch Dermatol. 1995 Oct. 131(10):1112-3. [QxMD MEDLINE Link].

16. George A, Bhatia A, Thomas E. Fox-Fordyce disease: a report of 2 cases responding to topical clindamycin. Indian J Dermatol Venereol Leprol. 2015 Jan-Feb. 81 (1):87-8. [QxMD MEDLINE Link].

17. Chae KM, Marschall MA, Marschall SF. Axillary Fox-Fordyce disease treated with liposuction-assisted curettage. Arch Dermatol. 2002 Apr. 138 (4):452-4. [QxMD MEDLINE Link].

18. Uzuncakmak TK, Karadag AS, Ozlu E, Akdeniz N, Cobanoglu Simsek B. Effective treatment of Fox-Fordyce disease with pulsed dye laser. Photodermatol Photoimmunol Photomed. 2016 Sep. 32 (5-6):311-313. [QxMD MEDLINE Link].

19. Pock L, Svrckova M, Machackova R, Hercogova J. Pimecrolimus is effective in Fox-Fordyce disease. Int J Dermatol. 2006 Sep. 45(9):1134-5. [QxMD MEDLINE Link].

20. Kaya Erdoğan H, Bulur I, Kaya Z. Clinical Effects of Topical Tacrolimus on Fox-Fordyce Disease. Case Rep Dermatol Med. 2015. 2015:205418. [QxMD MEDLINE Link].

21. Yang L, Zhang S, Wang T, He Z, Liu Y, Zdravković TP. Rapid remission with calcipotriol betamethasone in refractory Fox-Fordyce disease. Dermatol Ther. 2020 Mar. 33 (2):e13223. [QxMD MEDLINE Link].

22. Klager S, Kumar MG. Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease. Pediatr Dermatol. 2021 Jul. 38 (4):950-951. [QxMD MEDLINE Link].

Christopher R Gorman, MD Dermatologist, Central Virginia VA Health Care System

Christopher R Gorman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Richmond Academy of Medicine, Virginia Dermatology Society

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Mary Farley, MD Dermatologic Surgeon/Mohs Surgeon, Anne Arundel Surgery Center

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article